Director of Health, Safety & Environment
AdvanCell
Director of Health, Safety & Environment
AdvanCell
Manufactures Lead-212 for targeted alpha therapy
Salary Range: 175000 to 240000 (Currency: USD) (Pay period: per-year-salary)
The Director of Health, Safety & Environment (HSE) is responsible for developing, implementing, and maintaining the HSE programs and systems for AdvanCell's Andover manufacturing site. The role provides HSE oversight across all site operations, including manufacturing, laboratories, utilities, infrastructure, warehouse and logistics operations, waste management, contractor activities, and administrative areas.
As the Andover site is currently under construction, the role will initially focus on establishing the HSE organization, systems, processes, and culture required to support safe construction, commissioning, qualification, startup, and transition into GMP manufacturing operations. The role will partner closely with Engineering, Infrastructure, Manufacturing, MSAT, Quality, and other functional leaders to ensure HSE requirements are incorporated throughout facility development and operational readiness.
The role will have particular responsibility for establishing and maintaining radiation safety programs associated with the manufacture and handling of radiopharmaceutical products and radioactive materials. Experience with radioisotopes, radiopharmaceutical manufacturing, or other radiation-intensive manufacturing environments is highly preferred.
Following startup, the Director of HSE will assume full ownership of the site's HSE Management System and ongoing HSE performance, including occupational health and safety, radiation safety, environmental compliance, hazardous materials, emergency preparedness, industrial hygiene, contractor safety, waste management, and regulatory compliance.
As a member of the Andover Site Leadership Team, the Director of HSE contributes to strategic planning, organizational development, operational readiness, and cross-functional decision-making to achieve business objectives and support the site's growth into full GMP manufacturing and future commercial operations. Success in this role requires strong leadership, collaboration, adaptability, and the ability to build HSE capabilities in a dynamic and evolving environment.
Pre-Startup and Startup Phase:
AdvanCell develops radiopharmaceuticals for targeted alpha therapy, using Lead-212 and an on-demand Alpha Isotope Generator to produce the isotope daily. Its core product ADVC-001 targets PSMA to treat metastatic castration-resistant prostate cancer, evaluated in the multicenter TheraPb Phase I/II trial, while the company also pipelines other cancer therapies. The approach combines isotope production, drug manufacturing, and clinical development in a vertically integrated model to ensure reliable supply and faster development. Its goal is to speed patient access to radiopharmaceutical treatments by expanding its portfolio through collaborations, including a strategic partnership with Eli Lilly, and advancing clinical trials.
Explore more opportunities at AdvanCell